Thinking of Using Ivermectin This Flu Season? Here’s What the Research Says
Updated: Sep 29
Written by Elizabeth Chernoby in TheSkyMeds Editorial Standards
Medically reviewed by Jonathan Reed, Medical Content Reviewer Dec 8 2025
If you are thinking of using ivermectin this flu season, it is important to distinguish influenza from other infections and look at human clinical evidence rather than laboratory theories or social-media claims. Ivermectin is an antiparasitic medicine with established uses against certain parasitic infections, but it is not among the antiviral medicines recommended for treating seasonal influenza. Current CDC guidance recommends influenza-specific antivirals such as oseltamivir, zanamivir, peramivir, and baloxavir for appropriate patients. Evidence supporting ivermectin for influenza in humans is lacking, and there is no established flu-treatment dose for ivermectin. Taking large or inappropriate doses can also cause serious toxicity. Understanding what ivermectin actually treats—and what evidence-based flu treatment looks like—can help you avoid losing valuable treatment time during an influenza infection.
What Is Ivermectin Actually Used For?
Ivermectin is primarily an antiparasitic medicine, not an established influenza antiviral.
In the United States, oral ivermectin tablets are approved for specific parasitic worm infections, including intestinal strongyloidiasis and onchocerciasis. Certain topical ivermectin formulations have separate uses, including head lice and rosacea.
These indications are fundamentally different from influenza, which is caused by influenza viruses.
The FDA explanation of approved human ivermectin uses also emphasizes that animal ivermectin products are different formulations and should never be taken by humans.
Is ivermectin an antiviral medicine?
Calling ivermectin an “antiviral” without context can be misleading.
Researchers can test existing medicines against viruses in laboratory systems, and a compound may sometimes influence viral processes under experimental conditions. That does not establish that an achievable, safe dose will prevent illness or improve meaningful clinical outcomes in humans.
For influenza treatment, what matters is evidence from appropriately designed human studies demonstrating clinical benefit at an acceptably safe dose.
Current CDC influenza treatment recommendations do not include ivermectin.
What about ivermectin and COVID-19?
COVID-19 and influenza are separate viral illnesses caused by different viruses, so evidence about one should not automatically be transferred to the other.
FDA states that ivermectin has not been authorized or approved for prevention or treatment of COVID-19 and that currently available clinical-trial data do not demonstrate effectiveness against COVID-19 in humans.
That COVID-19 controversy also does not provide evidence that ivermectin treats influenza.
Evidence is disease-specific. A medicine's antiparasitic activity—or laboratory activity against a virus—does not establish that it treats influenza in people. For seasonal flu, current clinical recommendations use medicines with demonstrated activity against influenza viruses and supporting human evidence.
Does Ivermectin Treat Influenza?
There is no established clinical role for ivermectin in routine influenza treatment. Current CDC guidance for the 2025–2026 influenza season identifies four recommended antiviral medicines—oseltamivir, zanamivir, peramivir, and baloxavir—and ivermectin is not one of them.
This distinction is important when evaluating online claims.
Finding a biochemical hypothesis, cell-culture experiment, animal study, or research discussion involving a medicine does not establish that the drug improves influenza symptoms, reduces complications, prevents hospitalization, or saves lives in humans.
What would convincing evidence require?
Ideally, researchers would conduct well-designed controlled human trials comparing ivermectin with an appropriate control in people with confirmed or clinically suspected influenza.
Researchers would need to examine outcomes that matter to patients: symptom duration, complications, hospitalization, serious adverse effects, and potentially mortality in high-risk populations.
They would also need to establish a dose that produces relevant antiviral effects in humans without unacceptable toxicity.
Without that evidence, there is no scientifically established ivermectin regimen for seasonal influenza.
Why isn't laboratory evidence enough?
A drug concentration that affects a virus in a laboratory dish may not be safely achievable inside the human body.
The body also introduces variables that cell experiments cannot reproduce fully: drug absorption, metabolism, tissue concentrations, immune responses, age, other diseases, and interactions with other medicines.
Clinical treatment recommendations therefore rely heavily on human evidence rather than simply asking whether a drug showed an interesting laboratory effect.
Medicine | Established role | Influenza treatment status |
Ivermectin | Antiparasitic medicine with specific approved human uses | Not recommended by CDC as influenza treatment |
Oseltamivir | Neuraminidase inhibitor | Recommended option for influenza treatment |
Zanamivir | Inhaled neuraminidase inhibitor | Recommended for appropriate patients; not recommended for people with underlying airway disease such as asthma or COPD |
Peramivir | Intravenous neuraminidase inhibitor | Recommended option for appropriate patients |
Baloxavir | Cap-dependent endonuclease inhibitor | Recommended oral option for appropriate patients |
Amantadine/rimantadine | Older influenza A antivirals | Not currently recommended because of widespread resistance |
Which Medicines Are Actually Used to Treat Flu?
Current CDC guidance recommends four FDA-approved antiviral medicines for influenza in the United States: oseltamivir, zanamivir, peramivir, and baloxavir. The appropriate option depends on age, health conditions, pregnancy, illness severity, and other clinical factors.
The CDC guidance on treating influenza with antiviral medicines explains that treatment works best when started early, particularly within one to two days after symptoms begin.
For people who are hospitalized, severely ill, or at increased risk of serious influenza complications, prompt antiviral treatment is particularly important.
What is oseltamivir?
Oseltamivir is an oral neuraminidase inhibitor with activity against influenza A and B.
CDC recommends it as an influenza treatment option across age groups and recommends oral oseltamivir for hospitalized patients with suspected or confirmed influenza. It is also the preferred influenza antiviral during pregnancy because it has the greatest amount of supporting safety and benefit information among recommended flu antivirals.
Nausea, vomiting, and headache are recognized adverse effects.
What are zanamivir and peramivir?
Zanamivir is an inhaled neuraminidase inhibitor. It can treat uncomplicated influenza in appropriate patients aged 7 years and older but is not recommended for people with underlying airway diseases such as asthma or COPD because of the risk of bronchospasm.
Peramivir is an intravenous neuraminidase inhibitor approved for early treatment of uncomplicated influenza in people aged 6 months and older. Reduced kidney function can require dosage adjustment.
What is baloxavir?
Baloxavir works differently from neuraminidase inhibitors. It blocks a viral process needed for influenza replication and is administered as a single oral dose for eligible patients with uncomplicated influenza.
CDC describes it as an option for early treatment in people aged 5 years and older who meet appropriate criteria. It is also approved for post-exposure influenza prophylaxis in people aged 5 years and older.
Baloxavir is not recommended for treatment during pregnancy or breastfeeding because adequate efficacy and safety information is unavailable in these groups.
Why Does Flu Treatment Timing Matter?
Influenza antivirals provide their greatest clinical benefit when treatment begins early. CDC recommends starting indicated antiviral treatment as soon as possible, ideally within 48 hours after symptoms begin.
For otherwise healthy people with mild uncomplicated influenza, early treatment can shorten illness. For people at higher risk or with severe disease, antiviral treatment can be more important because influenza can lead to pneumonia, worsening of underlying conditions, hospitalization, and other complications.
Is it too late after 48 hours?
Not necessarily.
Although benefit is greatest when treatment starts early, CDC notes that treatment started later can still benefit people with severe, complicated, or progressive influenza and people who are hospitalized.
People at high risk of influenza complications should therefore contact a healthcare professional promptly when flu symptoms develop rather than deciding treatment is pointless because two days have passed.
Do you need a positive flu test first?
Not always.
For patients in priority treatment groups, CDC states that decisions to begin antiviral treatment should not wait for laboratory confirmation of influenza.
This matters during flu season because waiting several days for testing or experimenting with an unproven treatment can delay an evidence-based antiviral during the period when treatment may provide its greatest benefit.
Can Taking Ivermectin for Flu Be Harmful?
Yes. Using ivermectin without an established influenza indication can expose a person to adverse effects without demonstrated flu-treatment benefit, and it may delay appropriate assessment or antiviral treatment.
FDA warns that taking large doses of ivermectin can be dangerous. Reported toxicity can include nausea, vomiting, diarrhea, low blood pressure, allergic reactions, dizziness, balance problems, seizures, coma, and even death.
Even approved human doses can interact with other medicines, including some blood thinners.
Is veterinary ivermectin safe for humans?
No. Veterinary ivermectin should not be used by people.
Animal formulations may differ substantially from medicines designed and tested for humans. FDA reports receiving cases requiring medical attention, including hospitalization, after people self-medicated with ivermectin intended for animals.
The dose appropriate for a large animal can also expose a person to dangerous amounts of ivermectin.
Is there an ivermectin dose for flu?
There is no established, guideline-recommended ivermectin dose for treating seasonal influenza.
Trying to calculate a dose from parasite treatment, animal products, online forums, COVID-era protocols, or laboratory research is not an evidence-based way to treat flu.
A drug's dose is specific to its indication, formulation, patient characteristics, and supporting clinical evidence. A dose established for one infection cannot simply be transferred to a completely different disease.
What Should You Do If You Think You Have Flu?
Consider how severe your symptoms are and whether you are at increased risk of influenza complications. People who are hospitalized, severely ill, experiencing progressive symptoms, or at higher risk of complications are priority groups for prompt antiviral treatment.
Higher-risk groups include older adults, young children, pregnant people, and people with certain chronic medical conditions. Treatment decisions depend on individual circumstances.
If you belong to a higher-risk group and develop influenza-like symptoms, contacting a healthcare professional promptly can be more important than waiting to see whether symptoms resolve.
Do | Don't |
Contact a healthcare professional promptly if you are at high risk and develop flu symptoms | Do not substitute ivermectin for recommended influenza treatment |
Ask whether an influenza antiviral is appropriate | Do not assume every “antiviral” claim applies to influenza |
Start prescribed antiviral treatment promptly | Do not delay appropriate treatment while experimenting with unproven remedies |
Follow the prescribed dose and duration | Do not create an ivermectin flu dose from online protocols |
Tell clinicians about your health conditions and medicines | Do not assume ivermectin cannot interact with other drugs |
Use human medicines only for their appropriate indications | Never take veterinary ivermectin |
Follow current influenza prevention guidance | Do not rely on ivermectin as flu prevention |
How Can You Reduce Your Risk During Flu Season?
Vaccination remains an important component of seasonal influenza prevention, while influenza antivirals provide a separate tool for treatment and, with certain medicines and circumstances, prevention after exposure.
Antiviral medicines do not replace vaccination. CDC describes influenza antivirals as an important adjunct to influenza vaccination in preventing and controlling flu.
Everyday measures such as staying home when acutely ill, improving ventilation where practical, hand hygiene, and reducing exposure to others while contagious can also help limit respiratory-virus spread.
Can flu antivirals prevent influenza after exposure?
Some can be used for chemoprophylaxis—medication used to prevent infection after particular exposures.
For example, CDC states that baloxavir is approved for post-exposure prophylaxis in people aged 5 years and older, and oseltamivir and zanamivir also have preventive uses under appropriate circumstances.
Whether preventive medication is appropriate depends on the exposure, age, health risks, medication contraindications, and clinical guidance.
Ivermectin is not listed among CDC's recommended influenza chemoprophylaxis medicines.
When Should Flu Symptoms Receive Medical Attention?
Seek medical advice promptly if influenza is suspected in someone at increased risk of serious complications, including people with important chronic health conditions, pregnant people, young children, and older adults. Early antiviral treatment is particularly important for these groups.
Urgent medical assessment is appropriate for severe difficulty breathing, persistent chest pain or pressure, confusion, inability to stay awake, seizures, signs of severe dehydration, or other rapidly worsening symptoms.
Symptoms that improve and then return with significant fever or worsening respiratory illness can also warrant assessment because influenza can be complicated by secondary infections or worsening of underlying disease.
If someone has already taken excessive ivermectin or a veterinary ivermectin product and develops marked dizziness, vomiting, low blood pressure, difficulty walking, seizures, severe drowsiness, or altered consciousness, urgent medical evaluation is appropriate.
Conclusion
If you are thinking of using ivermectin this flu season, current evidence-based influenza guidance points elsewhere. Ivermectin has established antiparasitic uses, but it is not among the medicines recommended by CDC for treating or preventing seasonal influenza. Recommended flu antivirals include oseltamivir, zanamivir, peramivir, and baloxavir for appropriate patients, with treatment generally most beneficial when started early.
Avoid creating an ivermectin flu regimen from online claims, COVID-era discussions, or animal products. If you develop flu symptoms—particularly if you are pregnant, seriously ill, or at higher risk of complications—contact a healthcare professional promptly to discuss evidence-based treatment.
Frequently Asked Questions
1 . Does ivermectin work against influenza?
Ivermectin does not have an established clinical role in seasonal influenza treatment. Current CDC recommendations identify oseltamivir, zanamivir, peramivir, and baloxavir as recommended influenza antivirals. Ivermectin is not included, and there is no established guideline-recommended ivermectin regimen for treating seasonal flu.
2 . Is ivermectin an antiviral or an antiparasitic medicine?
Ivermectin is primarily an antiparasitic medicine. FDA-approved oral human uses include intestinal strongyloidiasis and onchocerciasis, while some topical formulations have other indications. Laboratory investigation of possible antiviral effects does not convert ivermectin into a clinically proven influenza antiviral or establish an effective flu-treatment dose.
3 . What antivirals are recommended for flu?
CDC currently recommends four influenza antivirals in the United States: oseltamivir, zanamivir, peramivir, and baloxavir. The appropriate medicine depends on age, pregnancy, underlying conditions, illness severity, and contraindications. Antivirals generally provide their greatest benefit when treatment begins soon after symptoms start.
4 . How quickly should flu antiviral treatment start?
Treatment provides the greatest benefit when started as soon as possible, ideally within 48 hours of symptom onset. Treatment can still benefit hospitalized patients and people with severe, complicated, or progressive influenza when started later. High-risk patients should seek advice promptly rather than waiting for symptoms to worsen.
5 . Is veterinary ivermectin safe to take for flu?
No. Veterinary ivermectin formulations are intended for animals and can differ from human medicines. FDA has received reports of people requiring medical attention, including hospitalization, after taking animal ivermectin. Large ivermectin doses can cause serious neurological and cardiovascular toxicity, seizures, coma, and potentially death.
6 . Can I take ivermectin to prevent getting flu?
Ivermectin is not recommended by CDC for influenza prevention. Certain influenza antivirals can be used for prevention in appropriate circumstances; for example, baloxavir has an approved post-exposure prophylaxis indication. Seasonal influenza vaccination remains an important preventive measure and antivirals do not replace vaccination.
Comments